Indeed, significantly higher levels of lipopolysaccharides (LPS) were detected in the plasma of patients with neurodegenerative diseases when compared with age-matched controls, with a correlation between LPS and NADPH oxidase 2 (NOX2) activation [5]. Here, CYBB is linked to neurodegenerative disease.